Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, announces today that it has signed a Letter of Engagement to retain Maxim Group LLC (“Maxim”) to provide financial advisory and investment banking services, including to assist in…